Inholz K, Bader U, Mundt S, Basler M
Int J Mol Sci. 2024; 25(11).
PMID: 38891837
PMC: 11172216.
DOI: 10.3390/ijms25115649.
Davenport B, Bullock C, McCarthy M, Hawman D, Murphy K, Kedl R
J Virol. 2020; 94(9).
PMID: 32102875
PMC: 7163133.
DOI: 10.1128/JVI.02036-19.
Schliehe C, Bitzer A, van den Broek M, Groettrup M
J Virol. 2012; 86(18):9782-93.
PMID: 22761378
PMC: 3446605.
DOI: 10.1128/JVI.00694-12.
Shedlock D, Talbott K, Cress C, Ferraro B, Tuyishme S, Mallilankaraman K
Vaccine. 2011; 29(39):6755-62.
PMID: 21238574
PMC: 3167034.
DOI: 10.1016/j.vaccine.2010.12.064.
Dow C, Oseroff C, Peters B, Nance-Sotelo C, Sidney J, Buchmeier M
J Virol. 2008; 82(23):11734-41.
PMID: 18829752
PMC: 2583689.
DOI: 10.1128/JVI.00435-08.
Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
Belnoue E, Fontannaz-Bozzotti P, Grillet S, Lambert P, Siegrist C
J Virol. 2007; 81(14):7338-50.
PMID: 17494081
PMC: 1933347.
DOI: 10.1128/JVI.00062-07.
Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II.
Homann D, Lewicki H, Brooks D, Eberlein J, Mallet-Designe V, Teyton L
Virology. 2007; 363(1):113-23.
PMID: 17320138
PMC: 1976554.
DOI: 10.1016/j.virol.2006.12.025.
Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought.
Masopust D, Murali-Krishna K, Ahmed R
J Virol. 2006; 81(4):2002-11.
PMID: 17151096
PMC: 1797597.
DOI: 10.1128/JVI.01459-06.
Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.
Rodriguez F, Harkins S, Slifka M, Whitton J
J Virol. 2002; 76(9):4251-9.
PMID: 11932390
PMC: 155093.
DOI: 10.1128/jvi.76.9.4251-4259.2002.
Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression.
SPENCE P, Sriram V, Van Kaer L, Hobbs J, Brutkiewicz R
Immunology. 2001; 104(2):168-74.
PMID: 11683957
PMC: 1783302.
DOI: 10.1046/j.1365-2567.2001.01302.x.
CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.
Rodriguez F, Harkins S, Redwine J, de Pereda J, Whitton J
J Virol. 2001; 75(21):10421-30.
PMID: 11581410
PMC: 114616.
DOI: 10.1128/JVI.75.21.10421-10430.2001.
Intralymphatic immunization enhances DNA vaccination.
Maloy K, Erdmann I, Basch V, Sierro S, Kramps T, Zinkernagel R
Proc Natl Acad Sci U S A. 2001; 98(6):3299-303.
PMID: 11248073
PMC: 30648.
DOI: 10.1073/pnas.051630798.
Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus.
Hudrisier D, Riond J, Gairin J
J Virol. 2001; 75(5):2468-71.
PMID: 11160751
PMC: 114831.
DOI: 10.1128/JVI.75.5.2468-2471.2001.
Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus.
Bartholdy C, Christensen J, Wodarz D, Thomsen A
J Virol. 2000; 74(22):10304-11.
PMID: 11044074
PMC: 110904.
DOI: 10.1128/jvi.74.22.10304-10311.2000.
CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
Boesen M, Svane I, ENGEL A, Rygaard J, Thomsen A, Werdelin O
Clin Exp Immunol. 2000; 121(2):210-5.
PMID: 10931133
PMC: 1905705.
DOI: 10.1046/j.1365-2249.2000.01292.x.
CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability.
Maloy K, Burkhart C, Junt T, Odermatt B, Oxenius A, Piali L
J Exp Med. 2000; 191(12):2159-70.
PMID: 10859340
PMC: 2193195.
DOI: 10.1084/jem.191.12.2159.
Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization.
Hassett D, Zhang J, Slifka M, Whitton J
J Virol. 2000; 74(6):2620-7.
PMID: 10684276
PMC: 111750.
DOI: 10.1128/jvi.74.6.2620-2627.2000.
Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity.
Doling A, BALLARD J, Shen H, Krishna K, Ahmed R, Collier R
Infect Immun. 1999; 67(7):3290-6.
PMID: 10377103
PMC: 116508.
DOI: 10.1128/IAI.67.7.3290-3296.1999.
Borna disease virus nucleoprotein (p40) is a major target for CD8(+)-T-cell-mediated immune response.
Planz O, Stitz L
J Virol. 1999; 73(2):1715-8.
PMID: 9882386
PMC: 104005.
DOI: 10.1128/JVI.73.2.1715-1718.1999.
Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice.
Seiler P, Kalinke U, Rulicke T, Bucher E, Bose C, Zinkernagel R
J Virol. 1998; 72(3):2253-8.
PMID: 9499083
PMC: 109522.
DOI: 10.1128/JVI.72.3.2253-2258.1998.